Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors

3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA). The results showed the models established by CoMFA (q(2) = 0.590, r(2) = 0.965) and CoMSIA (q(2) = 0.594, r(2) = 0.931) had good prediction ability. At the same time, 3D-QSAR models met the internal verification, external verification and AD test. Ten new compounds were designed based on CoMFA and CoMSIA contour maps and their pharmacokinetic/toxic properties (ADME/T) were evaluated. It was found that most compounds have well safety profile and pharmacokinetic property. Then, we explored the interaction between HDAC6 and compounds by molecular docking. The results showed that the binding mode of the new compounds with HDAC6 was the same as the template compound 46, and the hydrogen bond and hydrophobic bond played a vital role in the binding process. Molecular dynamics simulation results showed that residues Ser531, His574 and Tyr745 played key roles in the binding process. All newly designed compounds had lower energy gap and binding energy than compound 46 according to DFT analysis and free energy analysis. This study provided a theoretical reference for designing compounds of higher activity and a new idea for the development of novel HDAC6 inhibitors. [GRAPHICS] .

Automated summary

In this study, 3D-QSAR models were established to investigate the relationship between molecular structure and inhibitory activity for multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The models showed good predictive ability and passed internal verification, external verification, and AD testing. Molecular docking and dynamics simulation were used to explore the interaction between compounds and HDAC6. The study provided theoretical references for designing compounds with higher activity and offered a new idea for the development of novel HDAC6 inhibitors.